US Patent Issued to UNIVERSITY OF MARYLAND, BALTIMORE, GLYCOMANTRA on March 31 for "Compositions and methods for treating cancer with andrographolide and melatonin combination therapy" (Maryland, Virginia Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,088, issued on March 31, was assigned to UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore) and GLYCOMANTRA INC. (Baltimore).

"Compositions and methods for treating cancer with andrographolide and melatonin combination therapy" was invented by Aditi Banerjee (Catonsville, Md.), Steven Czinn (Pikesville, Md.), Hafiz Ahmed (Leesburg, Va.) and Thomas Blanchard (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating cancer in a subject, comprising administering to the subject an effective amount of a combination of andrographolide and melatonin. The present invention further provides compositions compris...